Kirovest Pharmaceutical Company S.A.E.
About Us
Founded in 1999, Kirovest is a national Egyptian company built on international standards of quality and manufacturing excellence. With a paid-in capital of EGP 500 million, we develop and market a broad portfolio of human and animal health products that support better healthcare outcomes and improve quality of life.
Contact
Contact us via email
Our team is here to support healthcare professionals, partners, and customers.
Send us your inquiry and we’ll respond as soon as possible.
Go to Contact Page
Kirovest Portfolio
Human & Animal Health
Human Health
View all human products
Cramlyptic
Antispasmodic
API: Pinaverium Bromide
Neurokirovest
Neuropatheic pain killer
API: Gabapentin
Stavrocoxx
Anti-inflammatory and pain relief for acute gouty arthritis
API: Etoricoxib
Animal Health
View all animal products
Tyilmac
Antibiotic
API: Tylosin tartrate
Spectradox 20%
Antibiotic
API: Doxycycline
Spectocin
Antibiotic
API: Spectinomycin
Patient Safety
Report Side Effects or Complications
If you experience any medical complications, side effects, or unexpected reactions while using our products, please contact us immediately.
Your report helps us ensure patient safety and comply with regulatory requirements.
Your report helps us ensure patient safety and comply with regulatory requirements.
About Kirovest
Achievements
Established in 1999, Kirovest Pharmaceutical Company S.A.E. is a national Egyptian company built on international standards of quality and manufacturing excellence.
Our Partners
